Teva Receives FDA Approval for Migraine Autoinjector
29.01.20 | Sophie Shulman
This site uses cookies to ensure the best viewing experience for our readers.
Ajovy
7 stories about Ajovy
Teva’s Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing
17.11.19 | Navit Zomer
Teva Is Pulling an Ace From its Sleeve in its Attempt to Reinvent Itself
11.11.19 | Uri Tal-Tene
Teva Discontinues Development of Cluster Headache Drug
24.04.19 | Tzally Greenberg
Market Indifferent to European Approval of Teva's Migraine Drug
02.04.19 | Lilach Baumer
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports
27.01.19 | Lilach Baumer
Teva Shares Rise Following FDA Approval of Migraine Drug
16.09.18 | Dror Reich
Tag does not exist. Please try again.